Cargando…
Remdesivir-Induced Extreme Sinus Bradycardia in COVID-19
During the COVID-19 pandemic, there was an urgent need for any medication to help reduce the high death rate experienced during this deadly surge. Remdesivir is an FDA-approved drug for COVID-19 treatment, given its anti-inflammatory properties. Upon extensive literature search, we found two studies...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Cureus
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9329595/ https://www.ncbi.nlm.nih.gov/pubmed/35910702 http://dx.doi.org/10.7759/cureus.27307 |
Search Result 1